Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Clinical
FDA/EMA/Drug Designation
FDA/EMA/Drug Designation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA/EMA/Drug Designation
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)
Biospace News
-
July 16, 2019
FDA/EMA/Drug Designation
Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-ANG3
FDA/EMA/Drug Designation
AstraZeneca’s immunotherapy Imfinzi granted orphan drug status by FDA for small-cell lung cancer
FDA/EMA/Drug Designation
FDA rejects Bausch Health, Eton’s EM-100 for allergic conjunctivitis
FDA/EMA/Drug Designation
AstraZeneca’s immunotherapy Imfinzi granted orphan drug status by FDA for small-cell lung cancer
FDA/EMA/Drug Designation
FDA rejects Bausch Health, Eton’s EM-100 for allergic conjunctivitis
Firstwordpharma News
-
July 12, 2019
0
FDA/EMA/Drug Designation
Govt revokes permit for gene therapy drug Invossa ...
Firstwordpharma News
-
July 4, 2019
0
FDA/EMA/Drug Designation
FDA clears Karyopharm’s nuclear export inhibitor Xpovio for refractory multiple myeloma
Firstwordpharma News
-
July 3, 2019
0
FDA/EMA/Drug Designation
Khondrion granted Orphan Drug Designation for KH176 for the treatment of...
Firstwordpharma News
-
July 2, 2019
0
FDA/EMA/Drug Designation
FDA Action Alert: Karyopharm, Merck and Celgene
Biospace News
-
July 1, 2019
0
1
2
3
...
20
Page 1 of 20
- Advertisement -
MOST POPULAR
B. Braun launches the First FDA-Approved Heparin Sodium Prefilled Syringe with...
April 24, 2019
New Clinical Data Analysis Shows Survival Benefit Three Years after Treatment...
February 14, 2019
AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD...
July 8, 2019
ProQR spins out all Dystrophic Epidermolysis Bullosa activities into newly formed...
March 26, 2019
Load more
HOT NEWS
In vivo
Gene therapy cassettes improved for muscular dystrophy: The next-generation versions made...
Others
Parvus and Genentech Forge Autoimmune Collaboration
Phase I
Provention Bio Announces Top-Line Results from its Phase 1b PULSE Clinical...
Commercial
Alpha Capital Partners to Launch Qualified Opportunity Zone Fund October...
